BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cardiac Science Corporation (CSCX) to Supply Q-Tel Data to AACVPR Cardiac Rehabilitation Registry


7/11/2012 10:55:34 AM

BOTHELL, Wash., July 10, 2012 /PRNewswire/ -- Cardiac Science Corporation, a global leader in external defibrillation, diagnostic devices and monitoring systems, has announced it will provide data from its Quinton® Q-Tel® Rehabilitation Management Systems to the American Association of Cardiovascular and Pulmonary Rehabilitation's (AACVPR) Outpatient Cardiac Rehabilitation Registry.

(Logo: http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO)

The web-based registry is the first of its kind in the United States and will provide cardiac rehabilitation professionals with means to track, document and communicate patient outcomes and program performance.

"We are honored to provide data to this national registry and help sponsor AACVPR in this vital effort to help rehabilitation programs obtain useful benchmarking data," said Neal Long, Cardiac Science president and chief executive officer.

"The registry will integrate with other AACVPR strategic initiatives, including program certification and performance measures, to increase program quality and provide data that are currently unavailable regarding the outcomes of cardiac rehabilitation," said Steven Lichtman, AACVPR 20112012 President.

When launched, the registry will allow cardiac rehabilitation professionals to track patient outcomes and program performance in accord with evidence-based guidelines. In addition, it will demonstrate the positive impact of cardiac rehabilitation on morbidity, mortality, physical function and quality of life for heart patients in the United States.

About AACVPR The American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) is a multidisciplinary professional association of health professionals who serve in the field of cardiac and pulmonary rehabilitation. Its membership includes cardiovascular and pulmonary physicians and nurses, exercise physiologists, physical therapists, behavioral scientists, respiratory therapists, dietitians, and nutritionists. Founded in 1985, the nonprofit association is dedicated to reducing morbidity, mortality, and disability from cardiovascular and pulmonary disease and improving the quality of life for patients and their families. Visit www.aacvpr.org to learn more.

About Cardiac Science
Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT.

For media inquiries, contact:
Anastasia Mironova
amironova@cardiacscience.com
+1.425.402.2092

For investor inquiries, contact:
ir@optoindia.com
+91.80.2852.8088

Access our company logo: http://www.cardiacscience.com/images/main_logo.gif

SOURCE Cardiac Science Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES